Biodel (BIOD) Stock Chart Video Analysis

Biodel Stock Chart Video Analysis

The Biodel Inc. (NASDAQ:BIOD) chart is holding a solid base that is turning into a rounded bottom. The pps is moving past a resistance at 65 cents and looking to breakout to possibly test old highs at 85 cents with a clear shot to $1 should that level fall.

Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients. We develop our product candidates by applying our proprietary formulation technologies to existing drugs in order to improve their therapeutic profiles. For further information regarding Biodel, please visit the company’s website at www.biodel.com.

Biodel (BIOD) Stock Quote and News:

Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/about-2/disclaimer.

0 comments

Add your comment

Commenting is allowed only for registered users.

Other articlesgo to homepage

	Markets Take Another Pounding(0) U.S. stocks were lower for a fifth day Thursday, as investors continued to fret about Greece”s future in the euro-zone. The Dow Jones Industrials closed down 156.06 points, or 1.2%, to 12,442.50 The S&P 500 demurred 19.94 points to 1,304.86. The tech-rich Nasdaq Composite Index capsized 60.35 to 2,813.69. Retail giants Wal-Mart and Sears Holdings

	Winning Brands Gets First Order from Canada(0) Winning Brands Corporation (Pink Sheets: WNBD) reported that it has received its first order for delivery of 1000+™ Stain Remover, World’s Most Versatile Cleaning Solution™, to a military facility, in Canada. 1000+ is manufactured by the Niagara Mist Marketing Division of Winning Brands. The first order is for product to be used at a Canadian

	Premiere Opportunities Partners with Flex Fuel Technologies(0) Totowa, New Jersey-based Premiere Opportunities Group, Inc. (OTCQB: PPBL) has signed an advisory agreement with Flex Fuel Technologies Inc. to assist the company with its strategic planning, EPA testing and budget planning for the future introduction of its products into the automotive aftermarket. Flex Fuel Technologies, Inc. has developed a ” bolt on technology,” called

	Pioneers in Regenerative Medicine Reshaping the Landscape of Biotechnology(0) Every industry or sector has pioneers that worked at the forefront of the field to shepherd new technologies into the mainstream. Oncology, for example, took huge steps forward as a result of the efforts of Dr. Sidney Farber, earning him the titles of “the father of the modern era of chemotherapy” and “father of modern

	Overhyped Social Media Stocks Highlight Value in CrowdGather(0) There is a lot of activity surrounding social media stocks with the Initial Public Offering of Facebook (NASDAQ: FB) coming on Friday. The new listing, which could see the company valued at as much as $100 billion, has investors and analysts already concerned that the world’s largest social network could be overvalued from the get-go.

Stay Informed

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Biodel Stock Chart Video Analysis

Biodel (BIOD) Stock Quote and News:

0 comments

Add your comment

Other articlesgo to homepage

Markets Take Another Pounding(0)

Winning Brands Gets First Order from Canada(0)

Premiere Opportunities Partners with Flex Fuel Technologies(0)

Pioneers in Regenerative Medicine Reshaping the Landscape of Biotechnology(0)

Overhyped Social Media Stocks Highlight Value in CrowdGather(0)

OTCBB News

Stay Informed

Dana-Farber to Host Cellceutix Trials

Diabetes Rate Growing Exponentially

Gateways

Contacts and information

Social networks

Most popular categories